Seaport Therapeutics, Inc. (SPTX)
19.98
-0.15
(-0.75%)
USD |
NASDAQ |
Nov 13, 16:00
19.93
-0.05
(-0.25%)
After-Hours: 19:59
Seaport Therapeutics Total Assets (Quarterly) : 417.62M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 417.62M |
| June 30, 2026 | 441.68M |
| Date | Value |
|---|---|
| March 31, 2026 | 227.67M |
| December 31, 2025 | 249.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 197.42B |
| Bristol Myers Squibb Co. | 88.77B |
| Harmony Biosciences Holdings, Inc. | 1.478B |
| ANI Pharmaceuticals, Inc. | 1.568B |
| Corcept Therapeutics, Inc. | 1.034B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.17M |
| Shareholders Equity (Quarterly) | 397.46M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 17.48 |
| Net Debt Paydown Yield | -0.09% |